Pfizer Inc. (PFE) Q3 2021 Earnings Results

Pfizer Beats on EPS, Stock Up 4.15%

Pfizer's strong EPS performance of $1.42, significantly above expectations, led to a positive stock reaction, with shares rising 4.15%. The company did not disclose revenue figures or future guidance, which leaves some uncertainty. Overall, the earnings report reflects Pfizer's solid performance in a competitive environment.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.42	N/A	+31.24%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to ongoing projects. However, they did not provide specific guidance for future quarters.

We are pleased with our EPS performance this quarter.

Our focus remains on delivering value through our ongoing projects.

Pfizer Beats on EPS, Stock Up 4.15%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Up 4.15%

Key numbers

Management commentary